-
Surfshark Adds Real-Time Call Protection to iOS App in Version 5.3.0
-
Samsung Galaxy Buds Active Leak Reveals ANC, Ear-Hook Design and One UI 9.5 Integration
-
Saudi PIF Retains Top Sovereign Wealth Fund Brand Title for Third Year
-
Egypt and Syria Sign Agreement to Restore Direct Flights After 14-Year Hiatus
-
Professor Shahida Moosa Pioneers Medical Genomics in South Africa Amid Testing Shortages
-
Van Gogh’s ‘Châtaigniers en Fleurs’ Sets $285m Record at Sotheby’s
-
Texas Marijuana Decriminalization Faces Uncertain Future Under New Attorney General
-
Anthropic Sets Record $81.3 Billion IPO Valuing AI Firm at $1.5 Trillion
-
Early Black Friday Laptop Deals: MacBook Neo, IdeaPad Slim 5x, and Surface Laptop Prices Drop
-
eThekwini Faces R6.5bn Flood Claim from Toyota’s Insurer
-
2026 East Bay Nosh Awards Voting Opens for Food and Drink Favorites
-
Increasing Electrification Raises Grid Risk and Cost Pressure for Industrial Sites, ABI Research Finds
-
multiQure Begins Manufacturing Phase of MQ-201 Gene Therapy for First Huntington's Disease Patients - U.S.-Based Andelyn Biosciences Selected as Manufacturing Partner
-
Arrive AI Eliminates All Debt Through Preferred Equity Exchange
-
QNX Brings Physical AI and Next-Generation Software-Defined Vehicle Innovation to CES 2027
-
More Than Half of Teen AI Chatbot Users Use Them Daily, and 46% Say It Feels Like Talking to a Human, New Family Online Safety Institute Research Finds
-
Valion Bio Welcomes Former U.S. Army Regulatory Leader and Biotech CEO Dr. Armand Balboni as Advisor in Run-up to Entolimod Therapeutic Efficacy Data Readout
-
MicroVision and Blue-Band to Support $3 Million Federally Funded Intelligent Transportation Initiative in Louisville, Kentucky
-
The 2026 MDaudit Annual Benchmark Report Spotlights AI's Impact on Financial Risk as Payer Denials and Audits Continue an Upward Trajectory
-
Metano Emerges From Stealth to Unify AI Agent Security Across the Enterprise
-
Lumber's Union CBA Agent Launches in Sage Agent Marketplace to Help Simplify Union Payroll Compliance
-
ATWEC Technologies, Inc. (OTCID: ATWT) Engages Michael Gillespie & Associates, PLLC to Audit Fiscal 2026 and 2025 Consolidated Financial Statements and Changes Fiscal Year End to October 31
-
Vogenx Set to Join the Russell 2000(R), Russell 3000(R), and Russell Microcap(R) Indexes
-
Stemtech Corporation Partners with Fitness Icon Tony Little to Launch Stemtech Biosciences Digital Campaign
-
Go Green Global Technologies Corp. Appoints Dennis Beckert as Interim Chief Executive Officer
-
InstaLILY Launches Lily for Sales on Microsoft Dynamics 365, Where Sellers and AI Agents Work Together in Shared Rooms
-
Wave AI, the AI Note Taker for In-Person Meetings, Passes 5 Million Recorded Hours
-
Celtic Bank Selects Infinant to Scale Its Embedded Finance Programs
-
NoHo, Inc. Acquires Four Placer Gold Claims in Clark County, Nevada from Gold Stake Mining Inc.
-
Making the Most of a Long Weekend Without Leaving Town
-
Bob's Watches Founder Paul Altieri Unveils Private Collection of Vintage Rolex Watches in New Book, "NOT FOR SALE"
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 19
-
Hemogenyx Pharmaceuticals PLC - Chairman Receives Prestigious Award
-
American Critical Minerals Reports High Grade Potash Intersection of 6.55m Grading 38.51 wt.% KCl at its Green River Project, Utah
-
LASE to Premiere Quantum Bullet(TM) at Counter UAS Technology Conference in Washington, D.C.
-
First Canadian Graphite Reports 43.9% Graphitic Carbon Sample and Encouraging Coarse-Flake Characteristics at Zone 13 at Lac Guéret South
-
IRS Shuts Down FIRE Today: What Information Return Filers Need to Know Before the 2027 Filing Season
-
Skilled Nursing Facilities Face 2027 Revenue Cycle Reckoning as Payer Burdens Reshape Admissions and Outsourcing
-
Trustpoint Xposure Completes More Than 200 AI Visibility Audits Across Professional Services
-
Gamma Resources Announces Expansion of Mesa Arc Uranium Project in New Mexico to 4,760 Acres, Completes Radon Flux Baseline Survey
-
Golden Minerals Completes Drilling Desierto, Argentina
-
Guanajuato Silver Reports Q3 Operating and Financial Results
-
Helio Corporation Engages CORE IR to Provide Investor Relations, Capital Markets Advisory and Media Relations Services
-
Greene Concepts Connects Consumer Needs with Manufacturing Strategy
-
Karbon-X (OTCQB:KARX) Enters California's Multi-Billion-Dollar Compliance Carbon Market Following CITSS Approval
-
BHG Financial Celebrates 25 Years of Innovation with Women in Technology Panel and Donates to Girls Who Code
-
Wildfire Season Is Over - The Legal Clock Is Not
-
Cosmos Health to Resume Share Repurchases as Insiders Commit to 12-Month Lock-Up
-
APPA Launches 2026 Pet Industry Holiday Gift Guide, Backed by New Pet Gifting Data
-
United Bancorp, Inc. Increases its Fourth Quarter Cash Dividend Payment to $0.20 per Share, which Produces a Forward Yield of 5.4%
WHO countries strike landmark agreement on tackling future pandemics
Years of negotiations culminated early Wednesday with countries agreeing the text of a landmark accord on how to tackle future pandemics, aimed at avoiding the mistakes made during the Covid-19 crisis.
After more than three years of talks and one last marathon session, weary delegates at the World Health Organization's headquarters finally sealed the deal at around 2:00 am (0000 GMT) Wednesday.
"Tonight marks a significant milestone in our shared journey towards a safer world," said WHO chief Tedros Adhanom Ghebreyesus.
"The nations of the world made history in Geneva today."
Five years after the emergence of Covid-19, which killed millions of people, devastated economies and upturned health systems, a sense of urgency hung over the talks, with new threats lurking -- including H5N1 bird flu, measles, mpox and Ebola.
The final stretch of the talks also took place under the shadow of cuts to US foreign aid spending and threatened tariffs on pharmaceuticals.
- 'It's adopted' -
Right until the last minute, disagreement lingered over a few thorny issues.
Negotiators stumbled over the agreement's Article 11, which deals with transferring technology for pandemic health products towards developing nations.
During the Covid-19 pandemic, poorer states accused rich nations of hoarding vaccines and tests.
Countries with large pharmaceutical industries have strenuously opposed the idea of mandatory tech transfers, insisting they must be voluntary.
But it appeared the obstacle could be overcome by adding that any transfer needed to be "mutually agreed".
The core of the agreement is a proposed Pathogen Access and Benefit-Sharing System (PABS), aimed at allowing the swift sharing of pathogen data with pharmaceutical companies, enabling them to quickly start working on pandemic-fighting products.
In the end, the 32-page agreement was entirely highlighted in green, indicating all of it had been fully approved by WHO member states.
"It's adopted," negotiations co-chair Anne-Claire Amprou announced, to thunderous applause.
"In drafting this historic agreement, the countries of the world have demonstrated their shared commitment to preventing and protecting everyone, everywhere, from future pandemic threats."
The finalised text will now be presented for sign-off at the WHO's annual assembly next month.
- 'More equity' -
As intense talks in corridors and closed rooms drew towards an end late on Tuesday, Tedros told reporters he thought the draft was "balanced", and that a deal would bring "more equity".
While taking measures to coordinate pandemic prevention, preparedness and response could be costly, "the cost of inaction is much bigger", he insisted.
"Virus is the worst enemy. (It) could be worse than a war."
The United States, which has thrown the global health system into crisis by slashing foreign aid spending, was absent.
US President Donald Trump ordered a withdrawal from the United Nations' health agency and from the pandemic agreement talks after taking office in January.
However, the US absence, and Trump's threat to slap steep tariffs on pharmaceutical products, still hung over the talks, making manufacturers and governments more jittery.
But in the end, countries reached consensus.
- 'Real work begins now' -
Looking ahead towards implementation, the leading pharma lobby said intellectual property and legal certainty would be essential if the industry was to invest in high-risk research and development in the next crisis.
"The pandemic agreement is a starting point," said David Reddy, director general of the International Federation of Pharmaceutical Manufacturers and Associations, which participated in the talks.
"We hope that in subsequent negotiations, member states maintain the conditions for the private sector to continue innovating against pathogens of pandemic potential."
Many saw the approval of the text as a victory for global cooperation.
"At a time when multilateralism is under threat, WHO member states have joined together to say that we will defeat the next pandemic threat in the only way possible: by working together," said New Zealand's former prime minister Helen Clark, co-chair of the Independent Panel for Pandemic Preparedness and Response.
As the congratulatory speeches continued on towards daybreak at the WHO HQ, Eswatini's representative cautioned that "whilst we celebrate this moment, we need not rest on our laurels.
"The real work begins now."
Y.Kobayashi--AMWN